GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - FRA:GXI - DE000A0LD6E6 - Common Stock
26.64 EUR
-0.46 (-1.7%)
Overall GXI gets a fundamental rating of 3 out of 10. We evaluated GXI against 19 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of GXI have multiple concerns. GXI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
GXI had a positive operating cash flow in the past year.
GXI had positive earnings in each of the past 5 years.
GXI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GXI has a worse Return On Assets (1.33%) than 78.95% of its industry peers.
GXI has a Return On Equity of 4.39%. This is in the lower half of the industry: GXI underperforms 78.95% of its industry peers.
With a Return On Invested Capital value of 3.59%, GXI is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for GXI is in line with the industry average of 7.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.33% | ||
| ROE | 4.39% | ||
| ROIC | 3.59% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a worse Profit Margin (2.89%) than 89.47% of its industry peers.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
GXI's Operating Margin of 8.03% is on the low side compared to the rest of the industry. GXI is outperformed by 78.95% of its industry peers.
GXI's Operating Margin has improved in the last couple of years.
GXI has a Gross Margin of 28.07%. This is in the lower half of the industry: GXI underperforms 78.95% of its industry peers.
GXI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.03% | ||
| PM (TTM) | 2.89% | ||
| GM | 28.07% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
GXI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GXI has about the same amount of shares outstanding.
The number of shares outstanding for GXI has been increased compared to 5 years ago.
GXI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.97, we must say that GXI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.97, GXI is doing worse than 78.95% of the companies in the same industry.
GXI has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
GXI's Debt to Equity ratio of 1.18 is on the low side compared to the rest of the industry. GXI is outperformed by 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.97 |
ROIC/WACC0.48
WACC7.55%
2.3 Liquidity
A Current Ratio of 1.01 indicates that GXI should not have too much problems paying its short term obligations.
GXI has a worse Current ratio (1.01) than 89.47% of its industry peers.
A Quick Ratio of 0.56 indicates that GXI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.56, GXI is doing worse than 94.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.56 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased by -7.16% in the last year.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.32%.
The Revenue has been growing slightly by 7.90% on average over the past years.
EPS 1Y (TTM)-7.16%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-27.42%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%19.57%
3.2 Future
GXI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.98% yearly.
Based on estimates for the next years, GXI will show a quite strong growth in Revenue. The Revenue will grow by 8.51% on average per year.
EPS Next Y-18.32%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
EPS Next 5Y8.98%
Revenue Next Year17.05%
Revenue Next 2Y11.28%
Revenue Next 3Y9.65%
Revenue Next 5Y8.51%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GXI is valuated cheaply with a Price/Earnings ratio of 6.42.
Based on the Price/Earnings ratio, GXI is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.40. GXI is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 5.55, the valuation of GXI can be described as very cheap.
Based on the Price/Forward Earnings ratio, GXI is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.94, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.42 | ||
| Fwd PE | 5.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GXI is valued cheaply inside the industry as 94.74% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.06 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.28%
EPS Next 3Y7.45%
5. Dividend
5.1 Amount
With a yearly dividend of 0.13%, GXI is not a good candidate for dividend investing.
In the last 3 months the price of GXI has falen by -43.49%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 0.69, GXI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, GXI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.13% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
69.83% of the earnings are spent on dividend by GXI. This is not a sustainable payout ratio.
GXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP69.83%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
FRA:GXI (10/17/2025, 7:00:00 PM)
26.64
-0.46 (-1.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners92.48%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap920.15M
Analysts72.17
Price Target62.12 (133.18%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.13% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP69.83%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.55%
Min EPS beat(2)-6.69%
Max EPS beat(2)17.79%
EPS beat(4)2
Avg EPS beat(4)6.98%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)4
Avg EPS beat(8)3.56%
EPS beat(12)7
Avg EPS beat(12)3.1%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)-0.6%
Revenue beat(16)6
Avg Revenue beat(16)-0.15%
PT rev (1m)-5.92%
PT rev (3m)-17.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.93%
EPS NY rev (1m)-0.87%
EPS NY rev (3m)-27.45%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-3.65%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-3.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.42 | ||
| Fwd PE | 5.55 | ||
| P/S | 0.42 | ||
| P/FCF | N/A | ||
| P/OCF | 3.84 | ||
| P/B | 0.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.06 |
EPS(TTM)4.15
EY15.58%
EPS(NY)4.8
Fwd EY18.02%
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)6.93
OCFY26.01%
SpS63.35
BVpS41.69
TBVpS-8.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.33% | ||
| ROE | 4.39% | ||
| ROCE | 4.85% | ||
| ROIC | 3.59% | ||
| ROICexc | 3.81% | ||
| ROICexgc | 7.75% | ||
| OM | 8.03% | ||
| PM (TTM) | 2.89% | ||
| GM | 28.07% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexcg growth 3Y-17.1%
ROICexcg growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.13 | ||
| Cap/Depr | 149.83% | ||
| Cap/Sales | 16.21% | ||
| Interest Coverage | 2.39 | ||
| Cash Conversion | 58.03% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 0.97 |
F-Score4
WACC7.55%
ROIC/WACC0.48
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.16%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-27.42%
EPS Next Y-18.32%
EPS Next 2Y1.28%
EPS Next 3Y7.45%
EPS Next 5Y8.98%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%19.57%
Revenue Next Year17.05%
Revenue Next 2Y11.28%
Revenue Next 3Y9.65%
Revenue Next 5Y8.51%
EBIT growth 1Y-16.38%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year113.62%
EBIT Next 3Y38.46%
EBIT Next 5Y24.57%
FCF growth 1Y-73.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.98%
OCF growth 3Y4.26%
OCF growth 5Y4.49%